Cite
SGLT2 inhibitor versus carbohydrate-restricted isocaloric diet: reprogramming substrate oxidation in type 2 diabetes
MLA
Hiroyuki Igarashi, et al. “SGLT2 Inhibitor versus Carbohydrate-Restricted Isocaloric Diet: Reprogramming Substrate Oxidation in Type 2 Diabetes.” Diabetology & Metabolic Syndrome, vol. 15, no. 1, Feb. 2023, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s13098-023-00990-6.
APA
Hiroyuki Igarashi, Hiroshi Uchino, Momoko Kanaguchi, Kaori Hisanaga, Genki Sato, Fukumi Yoshikawa, Masashi Furuta, Naohiro Washizawa, Shuki Usui, Masahiko Miyagi, & Takahisa Hirose. (2023). SGLT2 inhibitor versus carbohydrate-restricted isocaloric diet: reprogramming substrate oxidation in type 2 diabetes. Diabetology & Metabolic Syndrome, 15(1), 1–10. https://doi.org/10.1186/s13098-023-00990-6
Chicago
Hiroyuki Igarashi, Hiroshi Uchino, Momoko Kanaguchi, Kaori Hisanaga, Genki Sato, Fukumi Yoshikawa, Masashi Furuta, et al. 2023. “SGLT2 Inhibitor versus Carbohydrate-Restricted Isocaloric Diet: Reprogramming Substrate Oxidation in Type 2 Diabetes.” Diabetology & Metabolic Syndrome 15 (1): 1–10. doi:10.1186/s13098-023-00990-6.